These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5350744)

  • 1. Sero-immunity to poliomyelitis virus in Sweden 10 years after introduction of vaccinations with inactivated poliovirus vaccine. A pilot study.
    Böttiger M
    Acta Pathol Microbiol Scand; 1969; 76(1):106-16. PubMed ID: 5350744
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years.
    Böttiger M; Zetterberg B; Salenstedt CR
    Bull World Health Organ; 1972; 46(2):141-9. PubMed ID: 4537478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the sero-immunity that has protected the Swedish population against poliomyelitis for 25 years.
    Böttiger M
    Scand J Infect Dis; 1987; 19(6):595-601. PubMed ID: 2831621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliomyelitis vaccination in Thailand. I. A pilot study of the administration of live poliomyelitis vaccine.
    Sangkawibha N; Tuchinda P; Sakuntanaga P; Sunthornsaratul A; Kunasol P; Bukkavesa S; Ochasanonda P
    Southeast Asian J Trop Med Public Health; 1974 Jun; 5(2):171-8. PubMed ID: 4370270
    [No Abstract]   [Full Text] [Related]  

  • 5. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliomyelitis antibody titres in children and effect of live and inactivated poliovaccine.
    Reid D; Yetts R; Oddy CG; Benson PF
    Lancet; 1969 Mar; 1(7594):564-6. PubMed ID: 4179849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serological control over the state of immunity to the poliomyelitis virus in children].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN; Stepanova GS
    Vopr Virusol; 1974; (4):418-23. PubMed ID: 4373926
    [No Abstract]   [Full Text] [Related]  

  • 8. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against poliomyelitis.
    Beale AJ
    Br Med Bull; 1969 May; 25(2):148-52. PubMed ID: 4319086
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccinology of poliomyelitis.
    Salk D; Salk J
    Vaccine; 1984 Mar; 2(1):59-74. PubMed ID: 6099644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Swedish polio-protection is satisfactory. But before the disease is eradicated, everybody should be vaccinated].
    Böttiger M; Gustavsson O; Svensson A
    Lakartidningen; 1996 Jan; 93(3):138-41. PubMed ID: 8569326
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families.
    Böttiger M; Lagercrantz R
    J Pediatr; 1969 Jul; 75(1):30-8. PubMed ID: 4307138
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences of vaccination with inactivated poliovirus vaccine and epidemiology round a single case of polio in 1977 in Sweden.
    Böttiger M
    Dev Biol Stand; 1978; 41():133-6. PubMed ID: 223905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observation on safety of sequential vaccination schedule of different strain inactivated poliovirus vaccines].
    Huang ZY; Sun XD; Liu JC; Li Z; Ren J; Wu LL; Hu JY; Zhang JN
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):565-570. PubMed ID: 31177739
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination against poliomyelitis with inactivated vaccine beginning at 3, 4 and 9 months of age: a comparative study.
    Böttiger M; Larsson B
    J Biol Stand; 1980; 8(4):255-61. PubMed ID: 7204412
    [No Abstract]   [Full Text] [Related]  

  • 19. Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations.
    Salk D
    Rev Infect Dis; 1980; 2(2):258-73. PubMed ID: 6994208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio immunity to killed vaccine: an 18-year follow-up.
    Böttiger M
    Vaccine; 1990 Oct; 8(5):443-5. PubMed ID: 2251870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.